|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
2
|
Resverlogix Corp.
|
Sep 23, 2019 08:47AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 09:04AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 10:08AM
|
|
Re: Resverlogix Announces Participation at Leading, International Scientific Conferences
|
2
|
Resverlogix Corp.
|
Jun 10, 2019 10:15AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 12:25PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
4
|
Resverlogix Corp.
|
Mar 12, 2019 11:28AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
7
|
Resverlogix Corp.
|
Mar 12, 2019 01:55PM
|
|
Re: Resverlogix Announces Proposed Offering of Units
|
3
|
Resverlogix Corp.
|
May 14, 2019 06:51PM
|
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
1
|
Resverlogix Corp.
|
Jun 20, 2017 09:51AM
|
|
Re: Resverlogix Closes $10 Million of Equity Subscriptions
|
2
|
Resverlogix Corp.
|
Jun 20, 2017 12:00PM
|
|
Re: Resverlogix Corp. Selected to Present at Cavendish Global Health Impact Forum
|
4
|
Resverlogix Corp.
|
Oct 22, 2015 09:51AM
|
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
1
|
Resverlogix Corp.
|
May 30, 2017 02:37PM
|
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
2
|
Resverlogix Corp.
|
May 30, 2017 03:34PM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
4
|
Resverlogix Corp.
|
Jul 08, 2019 01:07PM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 02:40PM
|
|
Re: RVX & Esperion
|
3
|
Resverlogix Corp.
|
Mar 21, 2017 10:52AM
|
|
Re: RVX + FDA news - thoughts
|
2
|
Resverlogix Corp.
|
Feb 03, 2020 01:05PM
|
|
Re: RVX AGM 12 Dec 2017 meeting note, Q&A and comments
|
3
|
Resverlogix Corp.
|
Dec 18, 2017 09:01AM
|
|
Re: RVX announces...THIS IS FROM RVX
|
6
|
Resverlogix Corp.
|
Oct 13, 2017 10:03AM
|
|
Re: RVX announces...THIS IS FROM RVX
|
5
|
Resverlogix Corp.
|
Oct 13, 2017 10:20AM
|
